DE69528291D1 - Nicht-beta oxidierbare fettsäureanaloge,deren verwendung als therapeutisch wirksame medikamente sowie deren herstellung - Google Patents

Nicht-beta oxidierbare fettsäureanaloge,deren verwendung als therapeutisch wirksame medikamente sowie deren herstellung

Info

Publication number
DE69528291D1
DE69528291D1 DE69528291T DE69528291T DE69528291D1 DE 69528291 D1 DE69528291 D1 DE 69528291D1 DE 69528291 T DE69528291 T DE 69528291T DE 69528291 T DE69528291 T DE 69528291T DE 69528291 D1 DE69528291 D1 DE 69528291D1
Authority
DE
Germany
Prior art keywords
sub
beta
production
fatty acid
therapeutically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69528291T
Other languages
English (en)
Other versions
DE69528291T2 (de
Inventor
Rolf Berge
Jon Songstad
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE69528291D1 publication Critical patent/DE69528291D1/de
Application granted granted Critical
Publication of DE69528291T2 publication Critical patent/DE69528291T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DE69528291T 1995-07-14 1995-10-25 Nicht-beta oxidierbare fettsäureanaloge,deren verwendung als therapeutisch wirksame medikamente sowie deren herstellung Expired - Fee Related DE69528291T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO952796A NO952796D0 (no) 1995-07-14 1995-07-14 Fettsyre analoger med ikkeoksyderbart B-sete, fremstilling og anvendelse i krapeutiske preparater
PCT/NO1995/000195 WO1997003663A1 (en) 1995-07-14 1995-10-25 NON-β-OXIDIZABLE FATTY ACID ANALOGUES, THEIR USES AS THERAPEUTIC ACTIVE MEDICAMENTS, AND PREPARATION THEREOF

Publications (2)

Publication Number Publication Date
DE69528291D1 true DE69528291D1 (de) 2002-10-24
DE69528291T2 DE69528291T2 (de) 2003-05-08

Family

ID=19898394

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69528291T Expired - Fee Related DE69528291T2 (de) 1995-07-14 1995-10-25 Nicht-beta oxidierbare fettsäureanaloge,deren verwendung als therapeutisch wirksame medikamente sowie deren herstellung

Country Status (13)

Country Link
US (1) US6046237A (de)
EP (3) EP0840604B1 (de)
JP (1) JP3553966B2 (de)
KR (1) KR100394986B1 (de)
AT (1) ATE224188T1 (de)
AU (2) AU4272696A (de)
CA (1) CA2226871A1 (de)
DE (1) DE69528291T2 (de)
DK (1) DK0840604T3 (de)
ES (1) ES2183889T3 (de)
NO (1) NO952796D0 (de)
PT (1) PT840604E (de)
WO (1) WO1997003663A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7240398A (en) * 1998-05-08 1999-11-29 Rolf Berge Use of non-beta-oxidizable fatty acid analogues for treatment of syndrome-x conditions
AUPQ291499A0 (en) * 1999-09-17 1999-10-07 Women's And Children's Hospital Adelaide Novel nitro and sulphur containing compounds
AU784116B2 (en) * 1999-09-17 2006-02-09 Peplin Biolipids Pty Ltd Anti-cancer nitro- and thia-fatty acids
NO328803B1 (no) * 2000-03-03 2010-05-18 Thia Medica Nye fettsyreanaloger
NO20003591L (no) * 2000-07-13 2002-01-14 Thia Medica As Fettsyreanaloger for behandling av kreft
NO20006008L (no) * 2000-11-28 2002-05-29 Thia Medica As Fettsyreanaloger for behandling av inflammatoriske og autoimmune sykdommer
US7842727B2 (en) * 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US6495719B2 (en) 2001-03-27 2002-12-17 Circagen Pharmaceutical Histone deacetylase inhibitors
US7312247B2 (en) 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US8026280B2 (en) 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
FR2828487B1 (fr) 2001-08-09 2005-05-27 Genfit S A Nouveaux composes derives d'acides gras, preparation et utilisations
AU2003243272A1 (en) * 2002-05-22 2003-12-12 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
EP1515978A1 (de) 2002-06-20 2005-03-23 IC Vec Limited Schwefelhaltige phospholipidderivate
CA2506504A1 (en) * 2002-11-20 2004-06-03 Errant Gene Therapeutics, Llc Treatment of lung cells with histone deacetylase inhibitors
FR2850650B1 (fr) * 2003-01-31 2005-03-25 Genfit S A Utilisation therapeutique d'acylglycerols et de leurs analogues azotes et sulfures
FR2850869B1 (fr) * 2003-02-12 2005-03-25 Genfit S A Utilisations d'aminopropanediols acyles et de leurs analogues azotes et sulfures
US20090215895A1 (en) * 2004-01-30 2009-08-27 Peplin Biolipids Pty Ltd Therapeutic and carrier molecules
EP2275140B1 (de) * 2004-07-19 2017-11-01 Bergen Teknologioverforing AS Zusammensetzung enthaltend Pflanzen- oder Fischöl und nicht-oxidierbaren Fettsäuren-enthaltenden Komponenten
CA2587013A1 (en) * 2004-11-08 2006-05-18 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
WO2014140934A2 (en) 2013-03-11 2014-09-18 Life Science Nutrition As Natural lipids containing non-oxidizable fatty acids
CA2904898C (en) 2013-03-11 2019-10-15 Jan Remmereit Lipid compositions containing bioactive fatty acids
CN105498622B (zh) * 2015-12-10 2017-10-17 江南大学 一种含硒表面活性剂及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2208533A1 (de) * 1972-02-23 1973-09-27 Kolmar Laboratories Neue alkylthioaether
GB8813012D0 (en) * 1988-06-02 1988-07-06 Norsk Hydro As Non-b-oxidizable fatty acid analogues to reduce concentration of cholesterol & triglycerides in blood of mammals

Also Published As

Publication number Publication date
DE69528291T2 (de) 2003-05-08
PT840604E (pt) 2003-01-31
CA2226871A1 (en) 1997-02-06
AU4272696A (en) 1997-02-18
AU6124300A (en) 2000-11-30
DK0840604T3 (da) 2002-12-30
EP1232749A1 (de) 2002-08-21
WO1997003663A1 (en) 1997-02-06
KR19990028993A (ko) 1999-04-15
EP0840604A1 (de) 1998-05-13
EP0840604B1 (de) 2002-09-18
KR100394986B1 (ko) 2004-01-24
ATE224188T1 (de) 2002-10-15
JPH11514339A (ja) 1999-12-07
US6046237A (en) 2000-04-04
NO952796D0 (no) 1995-07-14
JP3553966B2 (ja) 2004-08-11
AU734431B2 (en) 2001-06-14
EP1232750A1 (de) 2002-08-21
ES2183889T3 (es) 2003-04-01

Similar Documents

Publication Publication Date Title
DE69528291D1 (de) Nicht-beta oxidierbare fettsäureanaloge,deren verwendung als therapeutisch wirksame medikamente sowie deren herstellung
EP0345038A3 (de) Nicht-beta-oxidierbare Fettsäure-Analoge, die die Blutkonzentration von Cholesterin und Triglyceriden bei Säugetieren senken
ES2131207T3 (es) Derivados de amidas del acido valproico y 2-valproenoico y su uso como anticonvulsivos.
AU564842B2 (en) Pyranyl (or cyclohexyl) methane sulfamates and their use as anticonvulsants
KR830006174A (ko) 기관지 항경련성 화합물 제조방법
ES484168A1 (es) Un procedimiento para preparar 9-(hidroxialcohil)-purinas
FR2691968B1 (fr) Nouveau procede de preparation d'un derive sterouide 11-ceto.
ES2004141A6 (es) Un procedimiento de preparacion de nuevas 1,4-dihidropiridinas
GR852867B (de)
FR2440353A1 (fr) Nouveaux arylethanols, leurs procedes d'obtention et leur emploi comme medicament
AU586477B2 (en) Hexenoic acids
ATE37393T1 (de) Mikroorganismusstamm chromobacterium violaceum, aus diesem hergestellte pharmazeutisch aktive verbindungen, ein verfahren zu deren herstellung und deren verwendung als medikamente.
ATE144507T1 (de) Dithian substituierte retinoide, ihre verwendung, verfahren zu ihrer herstellung, diese enthaltende kosmetische und pharmazeutische zusammensetzungen und ihre therapeutische verwendung
KR880012544A (ko) 벤젠설폰아미드 유도체 및 그의 제조방법
SE9701912D0 (sv) Pharmaceutical composition and use thereof
ATE27459T1 (de) 17-alpha-pregn-4-ene-3-oxo-21-carbonsauereester, verfahren zu deren herstellung und verwendung in arzneimitteln.
KR910000648A (ko) 페녹시피리딘아민 및 이의 유도체, 제조방법 및 약제로서의 용도
ATE1422T1 (de) Prostaglandinanaloge imidazolderivate, ein verfahren zu deren herstellung und eine pharmazeutische zusammensetzung, die diese enthaelt.
KR940005279A (ko) 아미딘을 함유하는 약제학적 조성물 및 아미딘
FR2485000B1 (de)
EP0653206A4 (de) Anti-hiv-wirkstoff.
DE3683073D1 (de) 3-oxo-2-azabicyclohexan-derivate, verfahren zu ihrer herstellung und verwendung dieser derivate als zwischenverbindungen fuer antibakterielle wirkstoffe.
HUT54371A (en) Process for producing macrolide compounds and pharmaceutical compositions containing them as active components
DE69327092D1 (de) Optisch aktives 1-phenylpyrrolidonderivat und dessen herstellung
IT1250625B (it) Derivati dell'eseridina utili per il trattamento delle malattie associaate a disordini colinergici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee